您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
CLEC3B His Tag Protein, Human

CLEC3B His Tag Protein, Human

货号: UA010128
价格: 3000
规格: 100μg
介绍: -
其他: -
产品规格
  • 物种

    Human
  • Accession

    P05452
  • 表达序列

    Glu22-Val202, with C-terminal 6*His

    EPPTQKPKKIVNAKKDVVNTKMFEELKSRLDTLAQEVALLKEQQALQTVCLKGTKVHMKCFLAFTQTKTFHEASEDCISRGGTLGTPQTGSENDALYEYLRQSVGNEAEIWLGLNDMAAEGTWVDMTGARIAYKNWETEITAQPDGGKTENCAVLSGAANGKWFDKRCRDQLPYICQFGIVGGGSHHHHHH

  • 表达宿主

    HEK293
  • 分子量

    24-30kDa (Reducing)
  • 纯度

    >95% by SDS-PAGE&RP-HPLC

  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    His Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 稀释度

背景介绍
  • C-type lectin domain family 3 member B (CLEC3B) is a hexameric, multimodular extracellular matrix protein with several molecular forms that are created through alternative splicing and protein modifications. It is highly conserved amongst vertebrates, and molecular phylogeny indicating that it evolved before fibronectin. CLEC3B has many extracellular binding partners, including matrix components, soluble factors and pathogens; it also influences cell phenotype directly through interactions with cell surface receptors. The synthesis of CLEC3B is strictly regulated, and it is widely distributed in embryonic tissues while restricted in adult tissues. CLEC3B is also de novo expressed in wound healing or pathological state, including chronic inflammation and cancer. First described as a modulator of cell adhesion, CLEC3B also directs a plethora of cell signaling and gene expression programs by shaping mechanical and biochemical cues in the cellular microenvironment. Exploitation of the pathological expression and function of CLEC3B is emerging as a promising strategy to develop new diagnostic, therapeutic and bioengineering tools.

  • 电泳JSON

    • 2μg (R: reducing conditions, N: non-reducing conditions).